Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome
Open Access
Abstract
Objective: Adults with Down syndrome (DS) often show elevated systemic inflammation, but the association with obesity, aging, and Alzheimer's disease (AD) pathology is not well understood. Methods: Data were drawn from 188 nondemented adults with DS participating in the Alzheimer Biomarkers Consortium‐DS (ABC‐DS). Participants completed clinical assessments, blood draws, and neuroimaging. Plasma biomarkers included indicators of general, pro‐, and anti‐inflammation. Mixed linear models tested associations between BMI, age, PET‐measured amyloid burden, and inflammatory biomarkers, adjusting for sex, trisomy type, and collection site. False discovery rate correction was applied. Results: The majority of the participants met criteria for obesity. Higher BMI was significantly associated with elevated levels of CRP, IL‐6, TNF‐α, B2M, IL‐18, and slCAM‐1 ( p < 0.05). Older age was significantly associated with higher B2M ( β = 1.22e + 05, p < 0.001). Amyloid burden was positively associated with IL‐6 ( β = 0.005, p = 0.037). Conclusions: Obesity, aging, and amyloid burden relate to systemic inflammation in adults with DS. Obesity showed the strongest and most consistent associations, emphasizing the value of regular monitoring and weight management strategies to help reduce inflammation. Aging and early amyloid accumulation showed more limited links with systemic inflammation; future work should examine whether these processes are more closely related to biomarkers of neuroinflammation as AD progresses.Keywords
Funding Information
- National Institute on Aging (F31 AG085730)
- National Institute on Aging (K01 AG083130)
- National Institute on Aging (R01 AG070028)
- National Institute on Aging (U01 AG051406)
- National Institute on Aging (U01 AG051412)
- National Institute on Aging (U19 AG068054)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50 HD105353)
- National Center for Advancing Translational Sciences (UL1 TR001873)
- National Center for Advancing Translational Sciences (UL1 TR002373)
- National Center for Advancing Translational Sciences (UL1 TR001414)
- National Center for Advancing Translational Sciences (UL1 TR001857)
- National Center for Advancing Translational Sciences (UL1 TR002345)
- National Center for Advancing Translational Sciences (UL1 TR002366)
- NIHR Cambridge Biomedical Research Centre
This publication has 59 references indexed in Scilit:
- Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome dataAlzheimer's & Dementia, 2025
- The Alzheimer's Biomarker Consortium–Down Syndrome (ABC‐DS): A 10‐year reportAlzheimer's & Dementia, 2025
- Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoringAlzheimer's & Dementia, 2024
- National population‐based estimates for major birth defects, 2016–2020Birth Defects Research, 2024
- Cardiometabolic profiles in children and adults with overweight and obesity and down syndromeAmerican Journal of Medical Genetics Part A, 2022
- Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeJAMA Network Open, 2022
- Gender and Sex Differences in Adipose TissueCurrent Diabetes Reports, 2018
- Estimation of live birth and population prevalence of Down syndrome in nine U.S. statesAmerican Journal of Medical Genetics Part A, 2017
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology, 2017
- Evidence for accelerated skin wrinkling among developmentally delayed individuals with Down's syndromeMechanisms of Ageing and Development, 1993